Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Compared to Norditropin® SimpleXx®

NCT01034202 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Growth Hormone Disorder
Healthy

Interventions

DRUG: NNC126-0083
DRUG: Norditropin® SimpleXx®
DRUG: placebo
DRUG: NNC126-0083
DRUG: Norditropin® SimpleXx®

Sponsor

Novo Nordisk A/S